NRXP

NRX Pharmaceuticals Inc

Stock NASDAQ – Stock Market Prices, News & Analysis

NRX Pharmaceuticals Inc is dedicated to developing innovative pharmaceutical treatments for respiratory and psychiatric disorders.

$ 2.94
3.52 %

NRX Pharmaceuticals Inc

$ 2.94
3.52 %
NRXP

NRX Pharmaceuticals Inc is dedicated to developing innovative pharmaceutical treatments for respiratory and psychiatric disorders.

Price history of NRX Pharmaceuticals Inc
Price history of NRX Pharmaceuticals Inc

Performance & Momentum

6 Months 6.35 %
1 Year 54.45 %
3 Years 49.40 %
5 Years 99.14 %

Strategic Analysis

NRX Pharmaceuticals Inc • 2026

NRX Pharmaceuticals Inc positions itself as a biopharma company focused on highly targeted medical needs, at the intersection of respiratory and psychiatric disorders. Its appeal as a stock rests more on the optionality linked to development programs than on an already mature industrial model, making it a speculative name within the healthcare sector.

Strengths
  • Exposure to two distinct therapeutic segments, which could broaden the sources of value creation if one program advances
  • Niche positioning in conditions with high unmet medical need, supporting scientific differentiation
  • Significant revaluation potential in the event of a clinical, regulatory, or partnership catalyst
Weaknesses
  • Highly dependent on clinical execution and study outcomes, with a high binary risk profile
  • Very poor stock market history, reflecting limited market confidence and substantial dilution risk
  • Commercial visibility likely remains weak as long as the assets are not validated or scaled up
Momentum

Recent momentum is positive and suggests a tactical rebound after a long phase of value destruction. However, the trend remains fragile given a very weak track record across multiple time frames, which means this should be viewed mainly as a short-term speculative signal rather than confirmation of a durable trend. In the absence of any notable recent news, the strategic read remains that of a catalyst-driven name, where the market is pricing in a potential turnaround more than an improvement already in place.

Similar stocks to NRX Pharmaceuticals Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone